CBS 2019
CBSMD教育中心
中 文

Pulmonary Hypertension

Abstract

Recommended Article

Update on chronic thromboembolic pulmonary hypertension Pulmonary artery denervation to treat pulmonary arterial hypertension: the single-center, prospective, first-in-man PADN-1 study (first-in-man pulmonary artery denervation for treatment of pulmonary artery hypertension) Medical Therapy for CTEPH: Is There Still Space for More? rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling Treatment Effects of Pulmonary Artery Denervation for Pulmonary Arterial Hypertension Stratified by REVEAL Risk Score: Results from PADN-CFDA Trial Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist? Right ventricular stroke work correlates with outcomes in pediatric pulmonary arterial hypertension Reply: Will Pulmonary Artery Denervation Really Have a Place in the Armamentarium of the Pulmonary Hypertension Specialist?

Clinical Trial2016 Dec 20;8(33):54106-54114.

JOURNAL:Oncotarget. Article Link

Pericardial effusion is correlated with clinical outcome after pulmonary artery denervation for pulmonary arterial hypertension

Chen SL,Stone GW, Zhang H et al. Keywords: clinical worse event; pericardial effusion; pulmonary arterial hypertension; pulmonary artery denervation; rehospitalization

Abstract